指南与共识慢性肾脏病遗传性与小管间质肾病水电解质与酸碱

儿童CKD-矿物质与骨异常诊疗循证指南(2024版)执行摘要

Executive Summary of Evidence-Based Guidelines for the Diagnosis and Treatment of Pediatric CKD-Mineral and Bone Disorder (Version 2024).
指南 / 共识 · Kidney Int Rep · 2026-06-03

该指南由中华医学会儿科学分会肾脏病学组发起制定,针对儿童慢性肾脏病-矿物质与骨异常(CKD-MBD)的诊疗问题给出循证推荐。儿童CKD-MBD涉及生化异常、骨转换/矿化/质量异常及异位钙化,既往缺乏儿童专属指南,本指南结合儿童生长发育特点与多学科专家意见形成个体化诊疗方案。

要点

  • 儿童CKD患者普遍存在矿物质代谢与骨结构异常,需按儿童特点管理。
  • 既往儿童CKD-MBD用药多沿用成人方案,缺乏针对性儿童循证指导。
  • 本指南由儿肾学组发起,结合多学科专家意见回答儿童CKD-MBD诊疗关键问题。

核心结论

  • 儿童CKD-MBD需基于儿童生长发育特点制定个体化诊疗方案,不能简单套用成人指南。

研究设计与样本

  • 由中华医学会儿科学分会肾脏病学组发起制定,结合成人、儿童、肾脏、营养及药学多学科专家意见。

主要发现

  • 儿童CKD患者普遍存在矿物质代谢与骨结构异常,与成人患者类似。
  • 既往无儿童专属CKD-MBD指南,儿童用药与临床实践多基于成人方案。

临床怎么用

  • 临床应结合儿童CKD临床特征与治疗目标,制定兼顾生长发育需求的个体化方案。

局限性

  • 原文为执行摘要,未报告具体推荐条款、证据等级及数值阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) in children refers to the systemic mineral and bone metabolism disorders caused by CKD, including biochemical abnormalities, abnormalities in bone turnover, mineralization, quality, and ectopic calcification. Like adult patients, mineral metabolism and bone structure abnormalities are universally present in children with CKD. However, there have been no guidelines specifically for children in the past. The medication treatment and clinical practices for children are usually based on those for adults, thus lacking targeted guidance. Children are in the process of growth and development, and adult guidelines do not take into account the characteristics of children. In addition, the medication range for children is different from that of adults, and new drugs have been verified and tested in children. Therefore, based on the developmental characteristics of children, combined with expert opinions about adults, children, kidney, nutrition, and medicine, this guideline was initiated by the Subspecialty Group of Nephrology, the Society of Pediatrics, Chinese Medical Association. It answers many important clinical questions related to the diagnosis and treatment of pediatric CKD-MBD, aims to provide individualized treatment plans considering the clinical characteristics of children with CKD and their treatment goals, while addressing the needs of their growth and development.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Wang M, Xiong HY, Zhu C, et al. Executive Summary of Evidence-Based Guidelines for the Diagnosis and Treatment of Pediatric CKD-Mineral and Bone Disorder (Version 2024). Kidney Int Rep. 2026. PMID: 42266556. doi:10.1016/j.ekir.2026.106493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。